Stenting not necessary in late treatment of heart attacks

February 18, 2009,

Two years ago, a major study found that many patients who receive delayed treatment for a heart attack do just as well with drugs alone as they do with drugs plus stents to prop open their blocked arteries. Now, further analysis shows that the drug option is cheaper and that there is no meaningful long-term difference in quality of life between the two options.

"The finding is just one more reason to question the use of routine stenting in late-treatment patients when cheaper, less invasive options are just as effective," says Daniel Mark, M.D., a member of the Outcomes Research Group at the Duke Clinical Research Institute and the lead author of the study appearing in the Feb. 19 issue of the New England Journal of Medicine.

The new study reports on the quality of life and medical expenses of patients enrolled in the Occluded Artery Trial (OAT), a study that compared optimal drug treatment with drugs plus stenting among patients who had suffered a heart attack but who received treatment days or even weeks after the first symptoms appeared.

Each year, about one million people in the U.S. suffer heart attacks. Studies show that the sooner treatment begins, the better - ideally, within a couple of hours. But in real life, about one-third of all patients are treated more than 12 hours after the first symptoms appear. During catheterization, many are found to have a 100 percent blockage in one of their arteries. At that point, there is no benefit in using clot-busting drugs, but doctors have long believed that placing a stent in such patients might still be helpful.

In the initial OAT trial, Judith Hochman, M.D., from New York University, and Mark, presented findings from a study of 2,166 patients showing that optimal medical therapy and medical therapy plus percutaneous coronary intervention, or PCI (using balloons and stents to open totally clogged arteries), were equally effective in stable heart attack patients whose treatment is delayed for days or even weeks. Now, in examining quality of life issues in the two groups, investigators say that while PCI does indeed produce modest benefits in reducing chest pain and improving functioning, those benefits do not last.

Mark and an international team of investigators examined how patients felt about their lives and the cost of the two approaches among 951 patients in the original study. Participants included patients who had suffered a heart attack anywhere from 3 to 28 days prior to enrollment who had a completely blocked artery but who were clinically stable and experiencing no chest pain. All of the enrollees received optimal medical therapy, but half were randomized to receive PCI as well.

Quality of life measures included the Duke Activity Status Index (DASI), which reflects cardiac function; the Medical Outcomes Study 36-Item Short-Form, which assesses a number of items, including pain, physical limitations, social function and vitality; and the Mental Health Inventory, which assesses psychological well-being. The questionnaires were administered face-to-face or by telephone upon enrollment in the study, and at 4, 12, and 24 months thereafter.

Investigators found that at four months, patients in the PCI group reported less chest pain and scored higher on the DSAI. But those differences were small and disappeared over time. By the end of the study, patients in the medical therapy group appeared to be doing just as well as those in the PCI group.

The researchers also compared the costs of the two treatments and the use of health care resources among a subgroup of patients in the United States. They found that during the first month of treatment, members of the PCI group stayed in the hospital 1.2 days longer than those in the medical group, mostly reflecting longer time in intensive care. They also found that the mean cost for hospital and physician care during the first 30 days after starting treatment was $22,859 for the PCI group and $12,683 for the medical therapy group. Overall, cumulative two-year costs were approximately $7,000 higher in the PCI group.

"What we have here is one of those cases where less is more," says Mark. "While it may seem that going an extra step in opening up clogged arteries even days after a heart attack, we know that clinically, it doesn't seem to offer the advantages we expected. Coupling that with the higher cost, we now know that adding PCI to standard medical care in opening blocked arteries more than a day after a heart attack is not good value. In an era when the high cost of health care is the subject of intense debate, this study offers us one way we can offer high quality care for less money."

"All heart attack patients should seek treatment right away to limit damage to the heart muscle," noted Elizabeth G. Nabel, M.D., director of the National Heart, Lung, and Blood Institute, which supported the study. "For the one-third of patients who do not receive immediate care - but who are otherwise stable - we have greater evidence of how treatments really affect them. Medical care is not just about immediate results and survival, but it is also about providing good quality of life and minimizing medical costs."

Source: Duke University Medical Center

Explore further: Statins are safe for children with abnormal cholesterol levels

Related Stories

Statins are safe for children with abnormal cholesterol levels

January 16, 2018
The charity says the findings will 'reassure' parents of children with familial hypercholesterolaemia (FH) – an inherited condition that significantly increases the risk of a heart attack in their 40s, 30s or even 20s.

Heart failure risk factors need a closer look

January 11, 2018
Assessing the risk of heart attack and stroke is a common practice among doctors and their patients; however, the risk factors for heart failure are not as clearly laid out or considered. A group of Baylor College of Medicine ...

Compared with medical treatment, percutaneous closure procedures prevent recurrent stroke

January 8, 2018
Two systematic evidence reviews and meta-analyses show that percutaneous closure procedures prevent recurrent stroke in patients with patent foramen ovale (PFO) compared with medical treatment alone. The first review was ...

Cardiac arrest survivors have trouble returning to work, social life

January 12, 2018
Tom Parker was 32 when his heart suddenly stopped. At home in Washington, D.C., his wife quickly started CPR with guidance from a 911 dispatcher. An emergency medical technician arrived on the scene minutes later. Using a ...

Alternative therapies for mild infections could help combat antibiotic resistance

December 29, 2017
Got a sore throat? The doctor may write a quick prescription for penicillin or amoxicillin, and with the stroke of a pen, help diminish public health and your own future health by helping bacteria evolve resistance to antibiotics.

Follow-up cholesterol testing reduces risk of reocurrence for heart attack and stroke patients

November 13, 2017
If you have a heart attack or stroke, it's important to get your "bad" cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated with a reduced risk of suffering ...

Recommended for you

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.